Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript

Page 4 of 4

Michael Petusky: I guess what I was really trying to get at, whatever production inefficiencies you’re referring to, has that been rectified? Has that been essentially fixed?

Michael Levitz: Yes.

Operator: There are no further questions at this time. Ladies and gentlemen, this concludes today’s conference call. Thank you for your participation. You may now disconnect.

Follow Anika Therapeutics Inc. (NASDAQ:ANIK)

Page 4 of 4